322 related articles for article (PubMed ID: 20086168)
1. Current multiple myeloma treatment strategies with novel agents: a European perspective.
Ludwig H; Beksac M; Bladé J; Boccadoro M; Cavenagh J; Cavo M; Dimopoulos M; Drach J; Einsele H; Facon T; Goldschmidt H; Harousseau JL; Hess U; Ketterer N; Kropff M; Mendeleeva L; Morgan G; Palumbo A; Plesner T; San Miguel J; Shpilberg O; Sondergeld P; Sonneveld P; Zweegman S
Oncologist; 2010; 15(1):6-25. PubMed ID: 20086168
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of novel therapies for the treatment of relapsed myeloma.
Richardson PG; Hideshima T; Mitsiades C; Anderson KC
J Natl Compr Canc Netw; 2007 Feb; 5(2):149-62. PubMed ID: 17335684
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib in the front-line treatment of multiple myeloma.
Richardson PG; Mitsiades C; Schlossman R; Ghobrial I; Hideshima T; Munshi N; Anderson KC
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1053-72. PubMed ID: 18588451
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma: novel approaches for relapsed disease.
Lonial S
Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 1():S18-23. PubMed ID: 18282362
[TBL] [Abstract][Full Text] [Related]
5. New treatments for multiple myeloma.
Richardson PG; Schlossman R; Hideshima T; Anderson KC
Oncology (Williston Park); 2005 Dec; 19(14):1781-92; discussion 1792, 1795-7. PubMed ID: 16506632
[TBL] [Abstract][Full Text] [Related]
6. Treatment of multiple myeloma: 2009 update.
Prescrire Int; 2009 Dec; 18(104):263-6. PubMed ID: 20025098
[TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed and refractory myeloma.
Kaufman J; Gleason C; Lonial S
Curr Hematol Malig Rep; 2009 Apr; 4(2):99-107. PubMed ID: 20425421
[TBL] [Abstract][Full Text] [Related]
8. Current status of bortezomib in the treatment of multiple myeloma.
Cavo M
Curr Hematol Malig Rep; 2007 May; 2(2):128-37. PubMed ID: 20425361
[TBL] [Abstract][Full Text] [Related]
9. Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.
Kumar S; Giralt S; Stadtmauer EA; Harousseau JL; Palumbo A; Bensinger W; Comenzo RL; Lentzsch S; Munshi N; Niesvizky R; San Miguel J; Ludwig H; Bergsagel L; Blade J; Lonial S; Anderson KC; Tosi P; Sonneveld P; Sezer O; Vesole D; Cavo M; Einsele H; Richardson PG; Durie BG; Rajkumar SV;
Blood; 2009 Aug; 114(9):1729-35. PubMed ID: 19561323
[TBL] [Abstract][Full Text] [Related]
10. Novel agents for relapsed and/or refractory multiple myeloma.
Thomas SK; Richards TA; Weber DM
Cancer J; 2009; 15(6):485-93. PubMed ID: 20010168
[TBL] [Abstract][Full Text] [Related]
11. Treatment of myeloma in patients not eligible for transplantation.
Jagannath S
Curr Treat Options Oncol; 2005 May; 6(3):241-53. PubMed ID: 15869735
[TBL] [Abstract][Full Text] [Related]
12. New therapies in multiple myeloma.
Merchionne F; Perosa F; Dammacco F
Clin Exp Med; 2007 Sep; 7(3):83-97. PubMed ID: 17972050
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and therapy of multiple myeloma.
Palumbo A; Cerrato C
Korean J Intern Med; 2013 May; 28(3):263-73. PubMed ID: 23682217
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.
Laubach JP; Schlossman RL; Mitsiades CS; Anderson KC; Richardson PG
Expert Rev Hematol; 2011 Feb; 4(1):51-60. PubMed ID: 21322778
[TBL] [Abstract][Full Text] [Related]
15. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival.
Palumbo A; Attal M; Roussel M
Clin Cancer Res; 2011 Mar; 17(6):1253-63. PubMed ID: 21411441
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide and CC-5013 in multiple myeloma: the University of Arkansas experience.
Barlogie B
Semin Hematol; 2003 Oct; 40(4 Suppl 4):33-8. PubMed ID: 15015894
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapy of multiple myeloma.
Kyle RA
Hematology; 2012 Apr; 17 Suppl 1():S125-8. PubMed ID: 22507799
[TBL] [Abstract][Full Text] [Related]
18. Genomic stratification of multiple myeloma treated with novel agents.
Jiang A; Reece D; Chang H
Leuk Lymphoma; 2012 Feb; 53(2):202-7. PubMed ID: 21823830
[TBL] [Abstract][Full Text] [Related]
19. Treatment of newly diagnosed myeloma.
Palumbo A; Rajkumar SV
Leukemia; 2009 Mar; 23(3):449-56. PubMed ID: 19005483
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma treatment strategies with novel agents in 2011: a European perspective.
Ludwig H; Beksac M; Bladé J; Cavenagh J; Cavo M; Delforge M; Dimopoulos M; Drach J; Einsele H; Facon T; Goldschmidt H; Harousseau JL; Hess U; Kropff M; Leal da Costa F; Louw V; Magen-Nativ H; Mendeleeva L; Nahi H; Plesner T; San-Miguel J; Sonneveld P; Udvardy M; Sondergeld P; Palumbo A
Oncologist; 2011; 16(4):388-403. PubMed ID: 21441574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]